Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
Holding UNCY?
Track your performance easily

Unicycive Therapeutics (UNCY) Financial Statements

274 Followers

Unicycive Therapeutics Financial Overview

Unicycive Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.885; its P/E ratio is -0.52; Unicycive Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 9.87M$ -2.54M$ -18.15M$ -4.32M$ -3.81M
EBITDA$ 9.87M$ -2.25M$ -18.07M$ -4.24M$ -3.73M
Net Income Common Stockholders$ 3.04M$ -21.17M$ -7.80M$ -4.41M$ -4.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 9.70M$ 14.35M$ 18.82M
Total Assets$ 44.70M$ 52.38M$ 14.19M$ 19.44M$ 22.88M
Total Debt$ 634.00K$ 923.00K$ 793.00K$ 866.00K$ 937.00K
Net Debt$ 634.00K$ 923.00K$ -8.91M$ -13.48M$ -17.88M
Total Liabilities$ 13.36M$ 30.65M$ 18.00M$ 16.01M$ 42.26M
Stockholders Equity$ -14.85M$ -24.46M$ -3.81M$ 3.39M$ -19.37M
Cash Flow-
Free Cash Flow$ -6.34M$ -6.46M$ -4.44M$ -4.42M$ -5.57M
Operating Cash Flow$ -6.32M$ -6.46M$ -4.44M$ -4.42M$ -5.56M
Investing Cash Flow$ -20.00K$ -6.00K--$ -12.00K
Financing Cash Flow$ -811.00K$ 45.69M$ -205.00K$ -51.00K-
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

Unicycive Therapeutics Debt to Assets

Unicycive Therapeutics Cash Flow

Unicycive Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis